Jieyi Wang is the founder of Lyvgen Biopharma. Lyvgen Biopharma has raised $30M in total funding. Latest round: Series B. Based in Shanghai, China.
Jieyi Wang is the founder of Lyvgen Biopharma, a biotechnology company based in Shanghai that develops novel immunotherapies. The company was founded in 2016 and recently completed a $30 million Series B funding round. Previously, Wang served as Senior Principal Research Scientist at AbbVie, bringing over 22 years of experience from Abbott and AbbVie in oncology and immunotherapy research.
Full founder directory · Investor directory · Company funding database · Fundraising library